Synnerstad I, Persson A E, Holm L
Department of Physiology and Medical Biophysics, Uppsala University, Sweden.
Acta Physiol Scand. 1997 May;160(1):103-11. doi: 10.1046/j.1365-201X.1997.00125.x.
We demonstrated previously that hydrochloric acid secreted from the gastric glands traverses the mucus layer in channels above the gland openings. The driving force for creation of these channels is most probably the hydrostatic pressure generated in the gastric gland lumen during stimulation of acid secretion. Here we investigated the effect of total inhibition of acid secretion on gland luminal pressure. Glandular pressure was measured in vivo with a pressure-sensitive microelectrode technique in Inactin-anaesthetized Sprague Dawley or Lewis x DA F1 rats. Glandular pressure was significantly reduced after ranitidine inhibition of acid secretion, from 17.2 +/- 2.1 mmHg during pentagastrin stimulation to 11.2 +/- 1.2 mmHg. This was also true when pentagastrin infusion was continued after inhibition of secretion with ranitidine. Omeprazole, however, did not significantly alter gland luminal pressure although it totally inhibited acid secretion. With continuation of pentagastrin infusion after omeprazole inhibition, glandular pressure increased significantly from 17.6 +/- 3.4 to 20.1 +/- 3.3 mmHg. In conclusion, total inhibition of acid secretion with ranitidine reduces but does not abolish gland luminal pressure. After omeprazole inhibition of acid secretion the gastric gland luminal pressure persisted or even increased. Since the volume secretion is lower after omeprazole administration than during pentagastrin stimulation, the outflow resistance most probably had increased after omeprazole injection. Suggestions for increased outflow resistance are narrowing in the upper part of the gland lumen by conformational changes of the cells or muscle contractions, and/or an increase in mucus secretion or viscosity.
我们之前证明,胃腺分泌的盐酸通过腺开口上方通道中的黏液层。形成这些通道的驱动力很可能是酸分泌刺激期间胃腺管腔内产生的静水压力。在此,我们研究了酸分泌完全抑制对腺管腔内压力的影响。在Inactin麻醉的斯普拉格-道利大鼠或刘易斯×DA F1大鼠中,使用压敏微电极技术在体内测量腺管压力。雷尼替丁抑制酸分泌后,腺管压力显著降低,从五肽胃泌素刺激期间的17.2±2.1 mmHg降至11.2±1.2 mmHg。在用雷尼替丁抑制分泌后继续输注五肽胃泌素时,情况也是如此。然而,奥美拉唑虽然完全抑制了酸分泌,但并未显著改变腺管腔内压力。在奥美拉唑抑制后继续输注五肽胃泌素时,腺管压力从17.6±3.4 mmHg显著增加至20.1±3.3 mmHg。总之,雷尼替丁完全抑制酸分泌可降低但并未消除腺管腔内压力。奥美拉唑抑制酸分泌后,胃腺管腔内压力持续存在甚至升高。由于奥美拉唑给药后容积分泌低于五肽胃泌素刺激期间,奥美拉唑注射后流出阻力很可能增加。流出阻力增加的原因可能是细胞构象变化或肌肉收缩导致腺管腔上部变窄,和/或黏液分泌或黏度增加。